376930 — NOUL Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for NOUL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	295	1,475	542	2,734	1,601
Cost of Revenue
Gross Profit	87.8	381	5.47	85.1	-879
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	7,561	12,913	16,174	18,873	24,396
Operating Profit	-7,266	-11,438	-15,632	-16,139	-22,795
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-8,973	-12,296	-13,675	-16,320	-22,469
Provision for Income Taxes
Net Income After Taxes	-8,973	-12,313	-13,680	-16,321	-22,469
Net Income Before Extraordinary Items
Net Income	-8,973	-12,313	-13,680	-16,321	-22,469
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-8,973	-12,313	-13,680	-16,321	-22,469
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-396	-547	-575	-564	-563
Dividends per Share